U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector transforms.
Related Posts
Election next week holds big implications for stock market, especially the control of Congress
The Nov. 5th election is set to remove a critical overhang for markets.
The Dow needs Nvidia to give chipmakers representation in index after Intel’s plunge
Intel has fallen so far so fast that the chipmaker’s stock price is no longer having an impact on the Dow Jones Industrial Average.
Trump victory may provide TikTok a lifeline to remain in the U.S.
Donald Trump’s election victory may provide a lifeline for TikTok, which faces a potential U.S. ban in January if not divested from parent company ByteDance.